The relationship among fructose intake, length of duodenal villi and small intestinal permeability in the patients of metabolic dysfunction-associated steatoic liver disease

UMIN ID: UMIN000055620

Registered date:27/09/2024

Basic Information

• Recruitment status: Recruiting
• Health condition(s) or Problem(s) studied: metabolic dysfuction-associated steatotic liver disease
• Date of first enrollment: 2024/09/27
• Target sample size: 100
• Countries of recruitment: Japan
• Study type: Observational

Outcome(s)

• Primary Outcome: fructose intake, length of duodenal villi, and small intestinal permeability

Key inclusion & exclusion criteria

• Age minimum: 18years-old
• Age maximum: Not applicable
• Gender: Male and Female
• Exclude criteria: 1) Patients with abnormalities that are presumed to affect intestinal permeability, such as intestinal inflammation 2) Patients with a history of gastrointestinal surgery other than cholecystectomy or appendectomy 3) Patients with gastrointestinal malignancies 4) Patients with obvious bleeding tendencies or blood clotting abnormalities 5) Other patients who are judged to be inappropriate by the principal investigator or the investigator

Related Information

• Primary Sponsor: Tokai University
• Source(s) of Monetary Support: Japan Society for the Promotion of Science (Japan)